Guanhao Biotech Co.,Ltd. (SHE:300238)

Guanhao Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	378.86	363.52	388.8	361.02	462.6	415.21
Other Revenue	13.97	13.97	15.38	16.27	26.38	21.75
Revenue	392.83	377.48	404.18	377.29	488.98	436.96
Revenue Growth (YoY)	5.21%	-6.60%	7.13%	-22.84%	11.91%	-0.21%
Cost of Revenue	84.87	78.83	88.26	159.6	125.38	125.09
Gross Profit	307.95	298.65	315.92	217.69	363.6	311.87
Selling, General & Admin	218.25	214.63	221.9	210.31	242.05	230.62
Research & Development	34.31	36.16	44.5	50.52	46.62	34.25
Other Operating Expenses	13.54	4.04	3.15	3.03	4.07	2.8
Operating Expenses	269.26	263.39	276.27	272.77	295.44	270.33
Operating Income	38.69	35.26	39.65	-55.08	68.16	41.54
Interest Expense	-3.38	-1.03	-1.78	-4.11	-7.36	-14.58
Interest & Investment Income	0.65	1.27	1.5	2.22	2.19	3.22
Currency Exchange Gain (Loss)	-0.12	-0.12	-3.52	-2.34	0.58	1.69
Other Non Operating Income (Expenses)	0.69	0.24	-4.11	1.11	-5.8	-2.81
EBT Excluding Unusual Items	36.53	35.62	31.74	-58.2	57.77	29.07
Impairment of Goodwill	-	-	-	-214.33	-0.15	-
Gain (Loss) on Sale of Investments	-10.84	-10.84	-3.64	-41.36	-4.68	-3.14
Gain (Loss) on Sale of Assets	0.03	0.03	0.92	0.03	0.33	-0.01
Asset Writedown	-6.59	-4.98	-0.29	-3.61	-0.05	-0.04
Other Unusual Items	9.68	8.19	3.35	24.9	28.83	19
Pretax Income	28.8	28.02	32.09	-292.58	82.06	44.88
Income Tax Expense	12.43	11.41	11.02	35.06	31.32	3.52
Earnings From Continuing Operations	16.38	16.61	21.07	-327.64	50.74	41.36
Minority Interest in Earnings	9.92	10.81	9.93	19.81	22.95	5.23
Net Income	26.3	27.42	31.01	-307.82	73.69	46.59
Net Income to Common	26.3	27.42	31.01	-307.82	73.69	46.59
Net Income Growth	49.68%	-11.58%	-	-	58.14%	-
Shares Outstanding (Basic)	266	274	258	265	263	259
Shares Outstanding (Diluted)	266	274	258	265	263	259
Shares Change (YoY)	-2.89%	6.11%	-2.63%	0.83%	1.66%	-2.65%
EPS (Basic)	0.10	0.10	0.12	-1.16	0.28	0.18
EPS (Diluted)	0.10	0.10	0.12	-1.16	0.28	0.18
EPS Growth	54.13%	-16.67%	-	-	55.56%	-
Free Cash Flow	17.99	-26.65	0.23	29.81	117.68	100.94
Free Cash Flow Per Share	0.07	-0.10	0.00	0.11	0.45	0.39
Gross Margin	78.39%	79.12%	78.16%	57.70%	74.36%	71.37%
Operating Margin	9.85%	9.34%	9.81%	-14.60%	13.94%	9.51%
Profit Margin	6.69%	7.26%	7.67%	-81.59%	15.07%	10.66%
Free Cash Flow Margin	4.58%	-7.06%	0.06%	7.90%	24.07%	23.10%
EBITDA	58.16	55.6	61.16	-31.56	94.51	69.72
EBITDA Margin	14.80%	14.73%	15.13%	-8.37%	19.33%	15.96%
D&A For EBITDA	19.46	20.34	21.51	23.52	26.35	28.18
EBIT	38.69	35.26	39.65	-55.08	68.16	41.54
EBIT Margin	9.85%	9.34%	9.81%	-14.60%	13.94%	9.51%
Effective Tax Rate	43.14%	40.73%	34.33%	-	38.17%	7.83%
Revenue as Reported	392.83	377.48	404.18	377.29	488.98	436.96
Advertising Expenses	-	10.97	12.39	9.43	15.72	8.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.